IL13RA2 and glioblastoma: For instance, outstanding clinical efficacy was reported in a patient with recurrent multifocal GBM with a regression of all intracranial and spinal tumors after administration of CAR T cells targeting IL-13Rα2 by means of locoregional delivery (ICT and ICV) [174].